Clinicaltrials.gov may not reflect the most up-to-date information on the trials shown.
*Trial status: active, not recruiting.
aIn collaboration with Arcus Biosciences.
FOLFIRI, FOLinic acid-Fluorouracil-IRInotecan regimen; GEJ, gastroesophageal junction; mCRC, metastatic colorectal cancer; mCRPC, metastatic castrate resistant
prostate cancer; mUC, metastatic urothelial cancer; NCT, national clinical trial.
1. National Cancer Institute. Cancer stat facts: Bladder Cancer. Accessed October 16, 2023. Available at: https://seer.cancer.gov/statfacts/html/urinb.html 2.
Gilead Sciences Inc. Second Quarter 2023 Resource Book. August 3, 2023. Available at:
https://s29.q4cdn.com/585078350/files/doc_financials/2023/q2/GILD-Q223-Resource-Book-10-August-2023.pdf